| 000 | 01420 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512092117.0 | ||
| 264 | 0 | _c19741010 | |
| 008 | 197410s 0 0 eng d | ||
| 024 | 7 |
_a10.1007/BF00421808 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, C | |
| 245 | 0 | 0 |
_aLithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents. _h[electronic resource] |
| 260 |
_bPsychopharmacologia _cApr 1974 |
||
| 300 |
_a263-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
| 650 | 0 | 4 | _aChlordiazepoxide |
| 650 | 0 | 4 | _aDextroamphetamine |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aExploratory Behavior _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperkinesis _xchemically induced |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aLithium _xadministration & dosage |
| 650 | 0 | 4 |
_aMethyltyrosines _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xantagonists & inhibitors |
| 700 | 1 | _aSanger, D J | |
| 700 | 1 | _aSteinberg, H | |
| 700 | 1 | _aTomkiewicz, M | |
| 700 | 1 | _aU'Prichard, D C | |
| 773 | 0 |
_tPsychopharmacologia _gvol. 36 _gno. 3 _gp. 263-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00421808 _zAvailable from publisher's website |
| 999 |
_c4157991 _d4157991 |
||